ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,429,133 | -44.6% | 2,513,044 | -35.8% | 0.40% | -53.8% |
| Q2 2023 | $18,837,696 | +17.4% | 3,916,361 | -0.9% | 0.87% | +32.3% |
| Q1 2023 | $16,045,120 | -24.8% | 3,952,000 | 0.0% | 0.66% | -26.5% |
| Q4 2022 | $21,340,800 | -43.7% | 3,952,000 | +4.6% | 0.90% | -48.4% |
| Q3 2022 | $37,902,000 | +160.1% | 3,778,818 | +21.9% | 1.74% | +81.2% |
| Q2 2022 | $14,570,000 | +43.4% | 3,100,000 | +19.3% | 0.96% | +46.9% |
| Q1 2022 | $10,162,000 | -22.2% | 2,599,098 | +34.5% | 0.65% | -29.3% |
| Q4 2021 | $13,067,000 | – | 1,933,040 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $14,180,861 | 4.20% |
| Knollwood Investment Advisory, LLC | 1,628,510 | $6,758,317 | 3.16% |
| Altium Capital Management LP | 650,000 | $2,697,500 | 1.41% |
| RA Capital Management | 14,932,063 | $61,968,061 | 1.22% |
| GREAT POINT PARTNERS LLC | 1,074,101 | $4,457,519 | 0.81% |
| Boxer Capital, LLC | 2,206,983 | $9,158,979 | 0.49% |
| Deep Track Capital, LP | 2,513,044 | $10,429,133 | 0.40% |
| Parkman Healthcare Partners LLC | 499,814 | $2,074,228 | 0.38% |
| Rock Springs Capital Management LP | 2,812,579 | $11,672,203 | 0.31% |
| Ghost Tree Capital, LLC | 150,000 | $622,500 | 0.20% |